Tianjin Ringpu Bio-Technology300119.SZValuation Analysis

As of Oct 19, 2026, Tianjin Ringpu Bio-Technology (300119.SZ) trades at a P/E of 21.40x, P/B of 1.59x, P/S of 2.17x, and a dividend yield of 2.43%.
Longitudinal percentile comparison: P/E sits at the 19th percentile over the trailing 10Y window (vs. 49th percentile over 3Y); P/B sits at the 11th percentile over the trailing 10Y window (vs. 26th percentile over 3Y); P/S sits at the 0th percentile over the trailing 10Y window (vs. 1st percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 22nd percentile within its industry and the 27th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.84%, ranking at the 92nd percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 8.0 points of each other — a consistent signal from both angles. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Of the 2.84% total shareholder yield, 2.43% is paid out as dividends and roughly 0.40% is implied to come from buybacks — both channels are meaningfully in play. Tianjin Ringpu Bio-Technology operates in the Agriculture, Forestry, Animal Husbandry and Fishery sector. Data refreshes weekly and is for reference only, not investment advice.